# Kalaris Therapeutics, Inc.: Form 8-K, filed Jan 10, 2025

- Company: [Kalaris Therapeutics, Inc.](/companies/klrs.md) (CIK 1754068)
- Form: 8-K
- Filed: 2025-01-10
- Accepted by EDGAR: Jan 10, 2025, 17:00 ET
- Period: 2025-01-09
- Accession: 0001193125-25-004527
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1754068/000119312525004527/d834173d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1754068/000119312525004527/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1754068/000119312525004527/d834173d8k.htm

Filed Jan 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-004527. Last ingested by Listed: Nov 11, 2026, 00:15 ET. No prices; not investment advice.